Dogwood Therapeutics, Inc.
DWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818844
No open-market purchases or sales by Dogwood Therapeutics, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $6.16M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Dogwood Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Dogwood Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Thomas John C | Director | 1,000 | Jun 17, 2026 | 1 |
| Whitley Richard James | Director | 700 | Jun 17, 2026 | 1 |
| De La Rosa Abel | Director | 4,000 | Jun 17, 2026 | 1 |
| Keefer David R | Director | 5,000 | Jun 17, 2026 | 1 |
| Walsh Angela | Chief Financial Officer | 3,000Indirect | Mar 6, 2026 | 2 |
| Grosswald Ralph | SVP OF OPERATIONS | – | Mar 6, 2026 | 2 |
| Gendreau Roger Michael | CHIEF MEDICAL OFFICER | – | Mar 6, 2026 | 2 |
| Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | 57,461 | Mar 6, 2026 | 2 |
| CK Life Sciences Intl (Holdings) Inc | Director, 10% Owner, Other: See Remarks | 2,842,638Indirect | Nov 25, 2025 | 1 |
| Sealbond Ltd | Director, 10% Owner, Other: See Remarks | 2,842,638Indirect | Nov 25, 2025 | 1 |
| Conjoint Inc. | Director, 10% Owner, Other: See Remarks | 2,842,638Indirect | Nov 25, 2025 | 1 |
| Pridgen William | Director | 52,045Indirect | Feb 28, 2024 | 0 |
| Burch Richard Alan | Director | – | Feb 28, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2023 (view filing) | Aug 21 | 1 day | Pridgen WilliamDirector | PPurchase | +15.3K | $1.30 | +$19.9K | +41.8%52.0K after | |
| Aug 18, 2023 (view filing) | Aug 17 | 1 day | Duncan Gregory ScottCHIEF EXECUTIVE OFFICER | PPurchase | +25.0K | $1.25 | +$31.3K | +77.0%57.5K after | |
| Dec 12, 2022 (view filing)1:39 PM ET | Dec 8 | 4 days | Whitley Richard JamesDirector | SSale | −1.80K | $0.2591 | −$466.38 | −72.0%700 after | |
| May 24, 2022 (view filing) | May 23 | 1 day | Walsh AngelaSVP OF FINANCE | PPurchase | +2.00K | $4.58 | +$9.16K | +200.0%3.00K after | |
| May 24, 2022 (view filing) | May 23 | 1 day | Duncan Gregory ScottCHIEF EXECUTIVE OFFICER | PPurchase | +7.50K | $4.52 | +$33.9K | +30.0%32.5K after | |
| May 19, 2022 (view filing) | May 18 | 1 day | Whitley Richard JamesDirector | PPurchase | +500 | $4.53 | +$2.27K | +25.0%2.50K after | |
| May 19, 2022 (view filing) | May 18 | 1 day | Pridgen WilliamDirector | PPurchase | +241 | $4.50 | +$1.08K | +0.7%36.7K after | |
| May 18, 2022 (view filing) | May 17 | 1 day | Pridgen WilliamDirector | PPurchase | +13.4K | $4.38 | +$58.9K | +58.4%36.5K after | |
| Mar 30, 2022 (view filing) | Mar 29 | 1 day | Pridgen WilliamDirector | PPurchase | +600 | $4.94 | +$2.96K | +2.7%23.0K after | |
| Mar 24, 2022 (view filing) | Mar 23 | 1 day | Pridgen WilliamDirector | PPurchase | +2.20K | $5.46 | +$12.0K | +10.9%22.4K after | |
| Jan 28, 2022 (view filing) | Jan 27 | 1 day | Pridgen WilliamDirector | PPurchase | +4.18K | $5.98 | +$25.0K | +28.7%18.7K after | |
| Jan 7, 2022 (view filing) | Jan 7 | Same day | De La Rosa AbelDirector | PPurchase | +4.00K | $5.90 | +$23.6K | New position4.00K after | |
| Jan 7, 2022 (view filing) | Jan 6 | 1 day | Whitley Richard JamesDirector | PPurchase | +1.80K | $5.72 | +$10.3K | +900.0%2.00K after | |
| Jan 5, 2022 (view filing) | Jan 4 | 1 day | Keefer David RDirector | PPurchase | +5.00K | $5.80 | +$29.0K | New position5.00K after | |
| Jan 4, 2022 (view filing) | Jan 3 | 1 day | Pridgen WilliamDirector | PPurchase | +2.21K | $5.43 | +$12.0K | +18.0%14.5K after | |
| Jan 4, 2022 (view filing) | Jan 4 | Same day | Thomas John CDirector | PPurchase | +1.00K | $5.65 | +$5.65K | New position1.00K after | |
| Dec 23, 2021 (view filing) | Dec 23 | Same day | Whitley Richard JamesDirector | PPurchase | +200 | $5.73 | +$1.15K | New position200 after | |
| Dec 22, 2021 (view filing) | Dec 21 | 1 day | Pridgen WilliamDirector | PPurchase | +8.83K | $5.66 | +$50.0K | +252.2%12.3K after | |
| Dec 22, 2021 (view filing) | Dec 21 | 1 day | Duncan Gregory ScottCHIEF EXECUTIVE OFFICER | PPurchase | +5.00K | $5.52 | +$27.6K | +25.0%25.0K after | |
| Jul 9, 2021 (view filing) | Jul 7 | 2 days | Pridgen WilliamDirector | PPurchase | +942 | $6.32 | +$5.95K | +0.1%710.7K after |